EUVIMEDObjevte EUVIMED
Multizentrische StudieQuerschnittstudieOpen access

Feasibility of Mobile Single-Lead Electrocardiogram Screening for Atrial Fibrillation: Multicenter Cross-Sectional Study

Robert Fenske, Denise Rossa, Christian Butter, Felix Muehlensiepen, Jonathan Nübel, Daniel Meretz, Oliver Ritter, Sebastian Spethmann, Rene Mantke, Mario Zerbaum, Nico Draheim, Nicole Lindenberg-Krause and 1 more

JMIR Cardio · 2026-09-10 · 10 · e92799-e92799

DOI: 10.2196/92799 ↗

At a glance

Multizentrische Studie in JMIR Cardio, published online on 2026-09-10. Written by Robert Fenske and 12 co-authors. Institution: Heart Center Brandenburg, Brandenburg Medical School (MHB) Theodor Fontane, Ladeburger Str. 17, Bernau, Brandenburg, 16321, Germany, 49 3338-694-649,…. Major MEDLINE topics: Atrial Fibrillation, Electrocardiography, Mass Screening. 18 references. The full text is freely available in PubMed Central.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Background

Atrial fibrillation (AF) is a major contributor of thromboembolic stroke. However, early detection remains challenging and is severely hindered by structural limitations in health care infrastructure. While current clinical guidelines recognize a 30-second single-lead electrocardiogram (ECG) as a standard diagnostic tool, the actual deployment and real-world utility of mobile screening technologies across health care settings remain poorly understood.

Objective

The primary objective of this study was to evaluate the real-world feasibility of a mobile single-lead ECG for the detection of AF in routine inpatient and outpatient settings. Feasibility was evaluated by the proportion of successfully completed recordings, patient acceptance, and the occurrence and characteristics of technical challenges during deployment.

Methods

This multicenter, cross-sectional pragmatic implementation study enrolled patients across 3 university hospitals and 3 primary care practices. Screening was performed using an US Food and Drug Administration (FDA)–approved single-lead ECG device (AliveCor KardiaMobile). Patients with an automated device reading indicating “Possible AF” and no prior diagnosis of AF underwent a confirmatory 12-lead ECG. Patient awareness and acceptance were evaluated using an exploratory, descriptive questionnaire.

Results

A total of 237 patients were enrolled (194 inpatients and 43 outpatients). The device algorithm provided an automatic interpretation in 95.3% (41/43) of the outpatients and 85.6% (166/194) of inpatients, resulting in an overall automated detection of AF in 21.5% (51/237) of the cohort. The algorithm identified newly suspected AF in 1.7% (4/237) of patients without a prior AF diagnosis. Of these, 1 case underwent same-day confirmatory 12-lead ECG and was confirmed as AF. Technical challenges occurred in 16.0% (38/237) of all recordings, with a numerical higher rate observed in the inpatient setting (34/194, 17.5% vs 4/43, 9.3% in outpatients; P =.25). Only 6.3% (15/237) of patients reported regular use of telemedicine applications.

Conclusions

Mobile single-lead ECG screening is feasible in routine inpatient and outpatient settings and identified a substantial prevalence of AF, which increased with age. The high detection rate underscores the potential of wearable ECG devices to facilitate early detection of AF. However, the absence of systematic confirmatory ECG testing and limited patient engagement with telemedicine applications highlight challenges in real-world implementation.

Subjects

MeSH terms (MEDLINE)

Atrial FibrillationElectrocardiographyMass ScreeningHumansCross-Sectional StudiesFemaleFeasibility StudiesMaleAgedMiddle Aged

Author keywords

AliveCoratrial fibrillationelectrocardiogrammobile healthscreeningsingle-lead ECGtelemedicine

Authors and institutions

  • Heart Center Brandenburg, Brandenburg Medical School (MHB) Theodor Fontane, Ladeburger Str. 17, Bernau, Brandenburg, 16321, Germany, 49 3338-694-649, 49 3338-694-644.
  • Center for Health Services Research (ZVF-BB), Faculty of Health Sciences Brandenburg, Brandenburg Medical School (MHB) Theodor Fontane, Rüdersdorf, Brandenburg, Germany.
  • Department of Cardiology, Nephrology and Pneumology, Faculty of Health Sciences Bradenburg, Brandenburg Medical School Theodor Fontane, University Hospital Brandenburg, Brandenburg an der Havel, Germany.
  • Department of Cardiology, Angiology and Intensive Care Medicine, Campus Mitte, German Heart Center at Charité - University Medical Center Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu…
  • DZHK (German Centre for cardiovascular research), Partner site, Berlin, Germany.
  • Department of Surgery, University Hospital Brandenburg, Brandenburg Medical School Theodor Fontane, Brandenburg, Germany.

Cite

APA

Fenske, R., Rossa, D., Butter, C., Muehlensiepen, F., Nübel, J., Meretz, D., Ritter, O., Spethmann, S., Mantke, R., Zerbaum, M., Draheim, N., Lindenberg-Krause, N., & Haase-Fielitz, A. (2026). Feasibility of Mobile Single-Lead Electrocardiogram Screening for Atrial Fibrillation: Multicenter Cross-Sectional Study. JMIR Cardio, 10, e92799-e92799. https://doi.org/10.2196/92799

Vancouver

Fenske R, Rossa D, Butter C, Muehlensiepen F, Nübel J, Meretz D, et al. Feasibility of Mobile Single-Lead Electrocardiogram Screening for Atrial Fibrillation: Multicenter Cross-Sectional Study. JMIR Cardio. 2026;10:e92799-e92799. doi:10.2196/92799

BibTeX
@article{Fenske2026,
  author = {Fenske, Robert and Rossa, Denise and Butter, Christian and Muehlensiepen, Felix and Nübel, Jonathan and Meretz, Daniel and Ritter, Oliver and Spethmann, Sebastian and Mantke, Rene and Zerbaum, Mario and Draheim, Nico and Lindenberg-Krause, Nicole and Haase-Fielitz, Anja},
  title = {Feasibility of Mobile Single-Lead Electrocardiogram Screening for Atrial Fibrillation: Multicenter Cross-Sectional Study},
  journal = {JMIR Cardio},
  year = {2026},
  volume = {10},
  pages = {e92799--e92799},
  doi = {10.2196/92799}
}
Start for free →